We are live on
!
Find out more
IAM
Impax Asset Management Portfolio holdings
AUM
$1.69B
Turnover
14.95%
1-Year Est. Return
16.26%
This Fund
S&P 500
This Quarter
Est. Return
+2.07%
1 Year Est. Return
+16.26%
3 Year Est. Return
+47.73%
5 Year Est. Return
+113.69%
10 Year Est. Return
–
AUM
$1.87B
AUM Growth
+$68.6M
(+3.8%)
Cap. Flow
+$28.4M
Cap. Flow
% of AUM
1.52%
Top 10 Holdings %
Top 10 Hldgs %
19.26%
Holding
216
New
25
Increased
87
Reduced
53
Closed
12
Avg Time Held Equity + Options
1.5
years
Top 10 Avg Time Held Equity + Options
0.9
years
Top 20 Avg Time Held Equity + Options
0.9
years
Avg Time Held Equity only
1.5
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$18.8M |
| 2 |
CVS Health
CVS
|
+$16.6M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$15.4M |
| 4 |
Genpact
G
|
+$13.3M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$13.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$20.1M |
| 2 |
ONE Gas
OGS
|
+$18.1M |
| 3 |
AbbVie
ABBV
|
+$17.2M |
| 4 |
Becton Dickinson
BDX
|
+$14.5M |
| 5 |
McDonald's
MCD
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.18% |
| 2 | Technology | 15.62% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Carter's
CRI
$1.15B
| $14.3M | 0.77% |
136,003
-20,003
| -13% | -$1.92M |
2014 Q4
5 quarters
|
|
|
52
Genpact
G
$6.23B
| $14.3M | 0.76% |
+524,959
| New | +$13.3M |
2016 Q1
0 quarters
|
|
53
Oshkosh
OSK
$7.84B
| $14.2M | 0.76% |
347,913
+25,695
| +8% | +$909K |
2014 Q4
5 quarters
|
|
|
LM
54
DELISTED
Legg Mason, Inc.
LM
| $14M | 0.75% |
403,145
+154,093
| +62% | +$4.83M |
2015 Q3
2 quarters
|
|
|
EBSB
55
DELISTED
Meridian Bancorp, Inc.
EBSB
| $13.8M | 0.74% |
991,528
+80,421
| +9% | +$1.1M |
2014 Q4
5 quarters
|
|
56
Spire
SR
$4.85B
| $13.8M | 0.74% |
203,694
-157,814
| -44% | -$10.1M |
2014 Q1
8 quarters
|
|
57
LyondellBasell Industries
LYB
$20.7B
| $13.2M | 0.71% |
154,741
-6
| -0% | -$482 |
2015 Q2
3 quarters
|
|
58
Emcor
EME
$31.8B
| $12.5M | 0.67% |
257,300
+32,300
| +14% | +$1.47M |
2015 Q3
2 quarters
|
|
|
ARRS
59
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $12.3M | 0.66% |
+538,289
| New | +$13.2M |
2016 Q1
0 quarters
|
|
|
WCIC
60
DELISTED
WCI Communities, Inc.
WCIC
| $12.3M | 0.66% |
660,052
+171,770
| +35% | +$3.23M |
2015 Q2
3 quarters
|
|
61
Goldman Sachs
GS
$257B
| $12.2M | 0.65% |
77,666
-30,006
| -28% | -$4.64M |
2013 Q4
9 quarters
|
|
62
Kearny Financial
KRNY
$567M
| $12M | 0.64% |
973,434
+127,462
| +15% | +$1.53M |
2015 Q3
2 quarters
|
|
63
Ecolab
ECL
$81B
| $11.8M | 0.63% |
105,766
+29,977
| +40% | +$3.18M |
2014 Q4
5 quarters
|
|
64
HomeTrust Bancshares
HTB
$778M
| $11.7M | 0.63% |
640,447
+73,064
| +13% | +$1.34M |
2015 Q1
4 quarters
|
|
65
Gilead Sciences
GILD
$194B
| $11.7M | 0.63% |
127,758
-57,396
| -31% | -$5.18M |
2013 Q2
11 quarters
|
|
66
Independent Bank
INDB
$3.78B
| $11.6M | 0.62% |
252,628
+15,800
| +7% | +$705K |
2015 Q1
4 quarters
|
|
67
EXL Service
EXLS
$5.99B
| $11.2M | 0.6% |
1,085,830
-237,165
| -18% | -$2.18M |
2014 Q4
5 quarters
|
|
68
DELISTED
MRC Global
MRC
| $11.2M | 0.6% |
850,000
-35,692
| -4% | -$411K |
2015 Q2
3 quarters
|
|
69
ICF International
ICFI
$1.6B
| $11.1M | 0.59% |
322,370
+67,756
| +27% | +$2.26M |
2015 Q2
3 quarters
|
|
|
FXCB
70
DELISTED
FOX CHASE BANCORP INC COM STK (MD)
FXCB
| $10.9M | 0.59% |
566,599
| – | – |
2013 Q3
10 quarters
|
|
|
KNL
71
DELISTED
Knoll, Inc.
KNL
| $10.8M | 0.58% |
499,793
+19,100
| +4% | +$359K |
2014 Q2
7 quarters
|
|
72
US Bancorp
USB
$91.5B
| $10.6M | 0.57% |
260,215
+1,014
| +0.4% | +$40.5K |
2015 Q3
2 quarters
|
|
|
BNCL
73
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $10.4M | 0.56% |
759,399
+386,912
| +104% | +$5M |
2015 Q3
2 quarters
|
|
74
DELISTED
Thermon Group Holdings
THR
| $10.1M | 0.54% |
575,106
+100,483
| +21% | +$1.69M |
2014 Q4
5 quarters
|
|
75
DELISTED
Hess
HES
| $9.48M | 0.51% |
+180,000
| New | +$7.96M |
2016 Q1
0 quarters
|
|
Similar funds
EA
OMCS
TPCM
CCM
AAC
IIM
CS
CCM
Impax Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Impax Asset Management held 216 positions worth $1.87B, up 3.8% from $1.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Impax Asset Management's Q1 2016 filing shows 25 new, 87 increased, 53 reduced and 12 closed positions. Its largest new stake was Genpact: 524,959 shares worth $14.3M. The largest sale was Express Scripts Holding Company, an estimated $20.1M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.
- Impax Asset Management's largest Q1 2016 buy was Genpact: 524,959 shares worth $14.3M.
- Impax Asset Management added most to Qualcomm in Q1 2016, an estimated $18.8M increase.
- Impax Asset Management's biggest Q1 2016 reduction was Express Scripts Holding Company, cutting an estimated $20.1M.
- Impax Asset Management fully exited AbbVie in Q1 2016, selling an estimated $17.2M.
- Impax Asset Management's ten largest holdings make up 19% of its $1.87B portfolio in Q1 2016.
- Impax Asset Management opened 25 new positions and closed 12 in Q1 2016.
- Impax Asset Management's portfolio value rose 3.8% quarter-over-quarter to $1.87B.
Based on Impax Asset Management's 13F filing for Q1 2016, filed 11 May 2016.